BARCLAYS PLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$3,048
+33.0%
175,525
+7.9%
0.00%
+100.0%
Q2 2023$2,291
+31.3%
162,658
+0.3%
0.00%0.0%
Q1 2023$1,745
+94.1%
162,179
+170.3%
0.00%
Q4 2022$899
-99.7%
60,007
+168.6%
0.00%
Q3 2022$287,000
+81.6%
22,341
+36.5%
0.00%
Q2 2022$158,000
-19.0%
16,372
-16.7%
0.00%
Q1 2022$195,000
-85.1%
19,661
-82.3%
0.00%
Q4 2021$1,306,000
+49.8%
111,068
+45.1%
0.00%
Q3 2021$872,000
+217.1%
76,560
+286.1%
0.00%
Q2 2021$275,000
-94.2%
19,829
-92.2%
0.00%
-100.0%
Q1 2021$4,729,000
-60.7%
255,536
-62.5%
0.00%
-50.0%
Q4 2020$12,031,000
+172.4%
680,900
+136.1%
0.01%
+100.0%
Q3 2020$4,417,000
+944.2%
288,388
+1638.1%
0.00%
Q2 2020$423,000
+336.1%
16,592
+166.5%
0.00%
Q1 2020$97,000
-52.0%
6,225
-66.0%
0.00%
Q4 2019$202,000
+106.1%
18,283
+60.1%
0.00%
Q3 2019$98,000
-35.1%
11,419
+2.4%
0.00%
Q2 2019$151,000
+88.8%
11,155
+155.6%
0.00%
Q1 2019$80,000
-7.0%
4,365
+42.9%
0.00%
Q4 2018$86,000
+38.7%
3,054
+25.7%
0.00%
Q3 2018$62,0002,4300.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders